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Abstract 
Purpose: To investigate the effect of polygonimitin C (PC) on bone formation and resorption in human 
osteoblast-like MG63 cells. 
Methods: MG63 cells were treated with PC at doses of 0, 20, 40 or 80 μg/mL for 48 h, with an 
untreated group as control. The effect of PC on alkaline phosphatase (ALP) activity in MG63 cells was 
investigated by p-nitrophenyl phosphate disodium hexahydrate assay. Western blot assay was used to 
evaluate the effect of PC on the expressions of osterix (OSX), bone morphogenetic protein-2 (BMP-2), 
runt-related transcription factor 2 (RUNX-2), osteocalcin (OC), fibronectin (FN), type I collagen (COL I), 
osteoprotegerin (OPG) and receptor activator of NF-κB ligand (RANKL) proteins in MG63 cells. 
Results: ALP relative activity in MG63 cells treated with PC at 20, 40 or 80 μg/mL (123.58, 137.74 or 
159.62 %, respectively) was significantly (p < 0.05 or 0.01) higher than that in control group (99.37 %). 
Expressions of OSX, BMP-2, RUNX-2, OC, FN, COL I and OPG proteins in MG63 cells treated with PC 
at 20, 40 or 80 μg/mL were significantly (p < 0.01) higher than those in control group. However, there 
were no statistically significant differences in RANKL protein expression between PC-treated MG63 
cells and control group. 
Conclusion: These results show that PC exerts protective effects against osteoporosis by promoting 
bone formation and inhibiting bone resorption. Thus, PC may be useful in the development of new anti-
osteoporosis drugs. 
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Osteoporosis (OP) is characterized by weak 
bone, which manifests clinically in bone fractures 
[1]. It is a major public health problem which 
affects numerous people worldwide, and 
imposes significant mental stress and economic 
burden on family and society [2]. The etiology of 
OP may be primary, secondary or idiopathic [3]. 
Typical primary OP is sub-divided into 
postmenopausal and senile OP, while secondary 
OP is sub-divided into endocrine, metabolic, 
drug-induced and deficiency OP [3, 4]. The 
pathogenesis of idiopathic OP is related to 
genetic factors [5]. Generally, OP results from 
imbalance between bone formation and bone 
resorption, which is controlled by bone-forming 
osteoblasts and bone-resorbing osteoclasts [6]. 
In OP patients, the bone-forming function of 
osteoblasts is lower than the bone-resorbing 
function of osteoclasts [7]. Therefore, the 
fundamental principle involved in the treatment of 
OP is to regulate the imbalance between the 
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bone-forming function of osteoblasts and bone-
resorbing function of osteoclasts. 
 
Studies have shown that the roots of Polygonum 
multiflorum Thunb. (Polygonaceae), also named 
as Polygoni multiflori Radix, have protective 
effects against OP [8-10]. It has been reported 
that stilbene glucoside, the main active ingredient 
of Polygoni multiflori Radix, increased bone 
mineral density and bone strength in rats, 
suggesting that stilbene glucoside may exhibit a 
protective effect against OP [11]. The chemical 
structure of polygonimitin C (PC) from Polygoni 
multiflori Radix is similar to that of stilbene 
glucoside [12]. This suggests that PC may also 
exhibit some effects on OP.  
 
Therefore, the aim of this work was to investigate 
the effect of PC on the bone formation and 







Polygoni multiflori Radix was purchased from 
Tongrentang Drugstore (Beijing, China) in 2013. 
It was authenticated by Xiao-Feng Yang, a 
taxonomist in the Department of Medicine, 
Hangzhou Medical College. A voucher specimen 
(no. HZMC 2013DM08) was deposited in the 
herbarium of Department of Medicine, Hangzhou 
Medical College for future reference. 
 
Chemicals and reagents 
 
Analytical grade ethanol, chloroform, ethyl 
acetate, n-butyl alcohol and methanol were 
purchased from Qingdao Haiyang Chemical Co., 
Ltd. (Qingdao, China). Macroporous resin D101 
and sephadex LH-20 were obtained from Qinshi 
Science and Technology Co., Ltd. (Zhengzhou, 
China) and Merck Millipore (Darmstadt, 
Germany), respectively. MEM medium and fetal 
bovine serum (FBS) were products of GIBCO 
(Waltham, MA, USA). Penicillin and streptomycin 
were obtained from Biological Industries (Kibbutz 
Beit Haemek, Israel). p-Nitrophenyl phosphate 
disodium hexahydrate (pNPP), enhanced BCA 
protein assay kit and polyviylidene difluoride 
(PVDF) membrane were purchased from Sigma-
Aldrich (Shanghai, China), Beyotime (Nantong, 
China) and Merck Millipore (Darmstadt, 
Germany), respectively.  
 
Primary antibodies for β-actin, osterix (OSX), 
bone morphogenetic protein-2 (BMP-2), runt-
related transcription factor 2 (RUNX-2), 
osteocalcin (OC), fibronectin (FN), type I 
collagen (COL I), osteoprotegerin (OPG) and 
receptor activator of NF-κB ligand (RANKL) were 
purchased from Bioss (Beijing, China), Cell 
Signaling Technology (Beverly, MA, USA) or 
Abgent (San Diego, CA, USA). Horseradish 
peroxidase (HRP)-conjugated goat anti-rabbit 
secondary antibody was obtained from Santa 
Cruz Biotechnology (Santa Cruz, CA, USA). 
Enhanced chemiluminescence detection kit for 
HRP was obtained from Biological Industries 
(Kibbutz Beit Haemek, Israel). 
 
Isolation of PC 
 
Air-dried and ground Polygoni multiflori Radix (30 
kg) was extracted by refluxing 95 % ethanol 
three times. The combined ethanol solvent was 
evaporated under reduced pressure to yield the 
ethanol extract (1964 g), which was dissolved in 
water and then successively partitioned with 
chloroform, ethyl acetate and n-butyl alcohol. 
The n-butyl alcohol solvent was evaporated 
under reduced pressure to yield the n-butyl 
alcohol extract (206 g), which was dissolved in 
water for further separation. The water-soluble 
fraction was subjected to macroporous resin 
D101 column, eluting with a gradient solvent 
system of ethanol-water to yield 30 % ethanol 
fraction.  
 
The 30 % ethanol fraction was chromatographed 
on Sephadex LH-20 column, eluting with 30 % 
methanol to yield fractions 1 - 7. Fraction 5 (14 g) 
was chromatographed over silica gel column 
chromatography, eluting with chloroform-ethyl 
acetate-methanol (volume ratio = 5: 3: 2) solvent 
system to yield PC (56 mg). The purity and 
chemical structure of PC were determined by 
area normalization method of high performance 
liquid chromatography (HPLC), mass spectrum 
(MS) data and nuclear magnetic resonance 
(NMR) data. PC was dissolved in 0.5 % DMSO 





MG63 cells were purchased from the American 
Type Culture Collection (ATCC, Manassas, VA, 
USA). The cells were cultured in MEM medium 
supplemented with 1 % penicillin, 1 % 
streptomycin and 10 % FBS at 37 ºC in a 
humidified atmosphere containing 5 % CO2. 
 
Grouping and treatment 
 
MG63 cells were seeded on 96-well culture 
plates at a density of 5 × 105 cells/well and 
divided into control and three doses of PC 
groups. After culture for 24 h, cells in control 
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group were treated with PC at a dose of 0 μg/mL 
for 48 h, and cells in three doses of PC groups 
were treated with PC at doses of 20, 40 or 80 
μg/mL for 48 h, respectively. All treatments were 
carried out in triplicate. 
 
Assay of alkaline phosphatase (ALP) activity 
 
After treatment with PC, MG63 cells were 
washed three times with PBS. Then the 
supernatant of MG63 cells were obtained with 
the aid of cell lysis buffer, ultrasound and 
centrifugation. According to the existing method 
in the literature [13], ALP activity in the 
supernatant was determined by pNPP assay. 
After reactions were completed, the absorbance 
(A) of each sample was read at 405 nm in a 
Multiskan MK3 microplate reader (Thermo, 
USA). Meanwhile, enhanced BCA protein assay 
kit was used to determine the protein 
concentration in the supernatant, and the 
absorbance value of each sample adjusted 
based on relatively stable protein concentration. 
The effect of PC on ALP activity in MG63 cells 
was evaluated by ALP relative activity, calculated 
as in Eq 1. 
 
ALP relative activity (%) = (At/Ac)100 …… (1) 
 
Where At and Ac are the absorbance of the test 
and control samples, respectively. 
 
Western blot assay 
 
MG63 cells were harvested after treatment with 
PC, and then their total proteins were extracted 
with the aid of cell lysis buffer, ultrasound and 
centrifugation. Enhanced BCA protein assay kit 
was used to determine the concentration of total 
proteins. Equal amounts of total proteins (about 
30 μg) were separated by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis and 
then transferred to a PVDF membrane. After 
blocking with 5 % non-fat milk, the PVDF 
membranes were incubated with primary 
antibodies for β-actin, OSX, BMP-2, RUNX-2, 
OC, FN, COL I, OPG and RANKL overnight at 
4ºC. Subsequently, the PVDF membranes were 
washed with Tris-buffer saline-Tween (TBS-T) 
and incubated with HRP-conjugated goat anti-
rabbit secondary antibody in TBS-T at room 
temperature for 2 h. Also, after being washed 
with TBS-T, the proteins on the PVDF 
membranes were detected on X-ray film by using 
enhanced chemiluminescence detection kit for 
HRP. β-actin was used as internal reference 
protein for equalizing protein loading. The 
expression level of target protein was expressed 




All data are presented as mean ± standard 
deviation (SD). Differences among different 
groups were analyzed by one-way ANOVA on 
SPSS 21.0 software (Chicago, IL, USA). 
Differences were considered statistically 




Purity and identification of PC 
 
Results of area normalization method in HPLC 
indicated that the purity of PC was 99.6 %. The 
chemical structure of PC (Figure 1) was identified 




Figure 1: Chemical structure of PC 
 
Effect of PC on ALP activity in MG63 cells 
 
As shown in Figure 2, after treatment with PC 
(20, 40 or 80 μg/mL), the ALP relative activities 
(123.58 ± 7.38 %, 137.74 ± 10.25 % or 159.62 ± 
12.17 %) in MG63 cells were significantly (p < 
0.05 or 0.01) higher than that in the control group 
(99.37 ± 5.49 %). 
 
 
Figure 2: Up-regulative effect of PC on ALP 
activity in MG63 cells; *p < 0.05, **p < 0.01, 
compared with that in the control group 
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Effects of PC on expressions of bone 
formation-related proteins in MG63 cells 
 
As shown in Figure 3, after treatment with PC 
(20, 40 or 80 μg/mL), expressions of OSX, BMP-
2, RUNX-2, OC, FN and COL I proteins in MG63 
cells were significantly (p < 0.01) higher than 
those in the control group. 
 
Effects of PC on expressions of bone 
resorption-related proteins in MG63 cells 
 
As shown in Figure 4, after treatment with PC 
(20, 40 or 80 μg/mL), the expression of OPG 
protein in MG63 cells was significantly (p < 0.01) 
higher than that in the control group, while the 
expression of RANKL protein in MG63 cells was 





MG63 cells are classic osteoblast-like cells for 
investigation of the effects of agents on bone 
formation and bone resorption [14,15]. In the 
present study, MG63 cells were used to assess 
the effect of PC on bone formation and bone 
resorption with the aid of pNNP and Western blot 
assays. 
 
The differentiation of pre-osteoblasts into mature 
osteoblasts is promoted by OSX and RUNX-2 
[16,17]. RUNX-2 plays an important role in early 
osteoblasts differentiation and promotes the 
formation of bone matrix proteins, such as ALP 
and COL I [16]. OSX is an important transcription 
factor in terminal osteoblasts differentiation and 
regulates the expressions of bone formation-
related proteins, such as OC and COL I [18,19]. 
 
 
Figure 3: Up-regulative effect of PC on expressions of bone formation-related proteins (OSX, BMP-2, 
RUNX-2, OC, FN and COL I) in MG63 cells; **p < 0.01, compared with those in the control group 
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Figure 4: Effect of PC on expressions of bone resorption-related proteins (OPG and RANKL) in 
MG63 cells; **p < 0.01, compared with that in the control group 
 
The differentiation of pre-osteoblasts into mature 
osteoblasts is enhanced by BMP-2 through up-
regulation of the expression of OSX [20]. OC, a 
key protein involved in osteoblasts differentiation 
and maturity, is positively related to the rate of 
bone formation and exhibits a regulative effect on 
extracellular matrix mineralization [21]. FN, an 
important cell adhesion factor, has a positive 
influence on osteoblasts differentiation and 
expression of COL I [22,23]. ALP and COL I are 
the main protein of reflecting osteoblasts 
functions [15]. Thus, ALP activity and the 
expressions of OSX, BMP-2, RUNX-2, OC, FN 
and COL I have positively influences on the 
differentiation of pre-osteoblasts into mature 
osteoblasts and on the osteoblasts functions. 
These indicate that ALP activity and the 
expression levels of these proteins are positively 
related to bone formation. In this study, PC 
significantly increased ALP activity and the 
expressions of OSX, BMP-2, RUNX-2, OC, FN 
and COL I in MG63 cells relative to those in the 
control group, suggesting that PC promoted the 
bone formation function of MG63 cells. 
 
Osteoclasts differentiation and maturity are 
enhanced by the combination of RANKL 
produced by osteoblasts and RANK [24]. The 
OPG produced by osteoblasts is a decoy 
receptor for RANKL and inhibits combination of 
RANKL and RANK [25]. Briefly, RANKL 
promotes osteoclasts differentiation and maturity, 
and OPG inhibits RANKL-induced osteoclasts 
differentiation and maturity. Thus, RANKL is 
positively related to bone resorption, and OPG is 
negative related to bone resorption. In this study, 
PC significantly increased the expression of OPG 
protein in MG63 cells without any effect on the 
expression of RANKL protein in MG63 cells 
relative to those in the control group, indicating 





The findings of this work indicate that PC 
promotes the bone formation function of MG63 
cells by up-regulating ALP activity and the 
expressions of bone formation-related proteins 
(OSX, BMP-2, RUNX-2, OC, FN and COL I). In 
addition, PC inhibits bone resorption function of 
MG63 cells by up-regulating the expression of 
bone resorption-related protein (OPG) without 
significant effect on the expression of bone 
resorption-related protein (RANKL). Thus, PC 
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